| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Commentary on “Pilot and Safety Trial of Carboplatin, Paclitaxel, and Thalidomide in Advanced Non–Small-Cell Lung Cancer”
|
Cohen, Ezra E.W.
|
|
2000
|
2 |
Supplement 2 |
p. 53-54
2 p.
|
artikel
|
| 2 |
Commentary on “Randomized Trial of Surgery Versus Radiotherapy in Patients with Stage IIIA (N2) Non–Small-Cell Lung Cancer After a Response to Induction Chemotherapy: EORTC 08941”
|
Rosell, Rafael
|
|
2000
|
2 |
Supplement 2 |
p. 73-
1 p.
|
artikel
|
| 3 |
Effect of HER2/neu Expression on Survival in Non–Small-Cell Lung Cancer
|
Korrapati, Vijaya
|
|
2001
|
2 |
Supplement 2 |
p. 216-219
4 p.
|
artikel
|
| 4 |
2000 Highlights From: 9th World Conference on Lung Cancer; Tokyo, Japan September 2000
|
D'Orazio, Amy
|
|
2000
|
2 |
Supplement 2 |
p. 93-96
4 p.
|
artikel
|
| 5 |
Irinotecan and Taxane Combinations for Non–Small-Cell Lung Cancer
|
Murren, John R.
|
|
2001
|
2 |
Supplement 2 |
p. S20-S25
6 p.
|
artikel
|
| 6 |
Irinotecan: Future Directions in Small-Cell Lung Cancer
|
Sandler, Alan
|
|
2001
|
2 |
Supplement 2 |
p. S9-S13
5 p.
|
artikel
|
| 7 |
Phase II Study of Pyrazine Diazohydroxide (NSC 361456) for Advanced Non–Small-Cell Lung Cancer
|
Blackstock, A. William
|
|
2000
|
2 |
Supplement 2 |
p. 62-66
5 p.
|
artikel
|
| 8 |
Pilot and Safety Trial of Carboplatin, Paclitaxel, and Thalidomide in Advanced Non–Small-Cell Lung Cancer
|
Merchant, Joseph J.
|
|
2000
|
2 |
Supplement 2 |
p. 48-52
5 p.
|
artikel
|
| 9 |
The Role of Gemcitabine and Paclitaxel as Second-Line Chemotherapy for the Treatment of Advanced Non–Small-Cell Lung Cancer (NSCLC)
|
Kakolyris, Stylianos
|
|
2000
|
2 |
Supplement 2 |
p. 43-47
5 p.
|
artikel
|
Tijdschrift beschrijving